ATS 2019 Virtual Final Program

P213 RDW at Hospital Admission May Predict Prognosis of the Patient with Acute Exacerbation of Interstitial Pneumonia/ Y. Nei, M. Momose, K. Nishiyama, A. Maeda, H. Nagano, S. Yamashiro, T. Kishaba, Uruma, Japan, p.A1465 P214 The Impact of Pulmonary Fibrosis in Puerto Rico/ G. Arocho-Pagan, R.I. Roman Carlo, J. Roman Rodriguez, M. Carero, V. Giorgio, O. Resta, M.P. Foschino Barbaro, Carero, M., Foggia, Italy, p.A1468 P215 Demographics and Characteristics at Diagnosis of Patients with Idiopathic Pulmonary Fibrosis (IPF) in a Real-World Setting: Findings from 382 Patients in the PROOF NEXT Registry/ W. Wuyts, B. Bondue, H. Slabbynck, A. Froidure, C. Dahlqvist, M. Schlesser, G.F. Joos, N. Gusbin, R. Peche, L. Bruggeman, Leuven, Belgium, p.A1467 P216 Incidence of Lung Cancer in Patients with IPF Treated by Pirfenidone or Nintedanib - a Real Life Multicentric Experience/ D. Lacedonia, V.A. Ventura, M. Mesto, L. Iamele, L. Labate, L. Refolo, F.G. Salerno, R. de Tullio, E. Tedeschi, M. Rollo, I. Caccavo, G. Patricelli, E. Profilo, M. Carone, P. di Napoli, V. Picca, E. Sabato, V. Giorgio, O. Resta, M.P. Foschino Barbaro, Fog, p.A1468 P217 Interstitial Lung Disease Characteristics at the Veterans Affairs Long Beach Healthcare System/ K.M. Stern, R. Reddy, Orange, CA, p.A1469 CLINICAL THEMATIC POSTER SESSION A39 DRUG RELATED CASE REPORTS 9:15 a.m. - 4:15 p.m. KBHCCD Area D (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : K. Suresh, MD, Baltimore, MD P469 When the Solution Is the Problem Successful Treatment of Etanercept Induced Granulomatous Interstitial Lung Disease with an Alternate Anti Tumor Necrosis Factor Alpha Inhibitor/ S. Blumhof, R. Crowe, P. Acosta Lara, T. Kulkarni, T. Luckhardt, Birmingham, AL, p.A1470 P470 Acute Amiodarone Lung Toxicity Following Non Cardiac Surgery: A Rare Phenomenon/ K. Jakharia, S. Cassady, N.G. Shah, E.J. Britt, Washington, DC, p.A1471 P471 Imatinib-Induced Pneumonitis Associated with “Radiation-Recall” Pattern in a Patient with Chronic Myelogenous Leukemia and Prior Chemotherapy, Radiation Therapy, and Immunotherapy for Non-Small Cell Lung Cancer/ H. Naiditch, C. Brandsdorfer, J.D. Possick, New Haven, CT, p.A1472 P472 Acute Drug-Induced Pneumonitis from Brentuximab Therapy/ S. Katta, T. Connolly, Houston, TX, p.A1473 P473 Daptomycin Induced Acute Eosinophilic Pneumonia: A Case Report/ H. Rawal, U. Sagheer, B.S. Bhandari, S.R. Selinger, Baltimore, MD, p.A1474 P474 The Long Lasting Burn of Kerosene: Cavitating Pulmonary Masses from Hydrocarbon Pneumonitis/ A. Sharaan, Z. Syed, M.R. Alziadat, R. Yelisetti, A. Samuel, M. Ismail, J. Mathew, Paterson, NJ, p.A1475 P475 A Case of Eosinophilic Pneumonia Secondary to Ustekinumab in the Treatment of Crohn’s Disease/ G. Colbenson, D.R. Nelson, Rochester, MN, p.A1476 P476 Hypereosinophilic Syndrome with Acute Respiratory Failure Due to Severe Obstructive Airway Disease in a Patient Receiving Pembrolizumab/ R.D. Struble, Z. Holliday, T.J. Gross, Iowa City, IA, p.A1477 P477 Talc Granulomatosis Masquerading as a Tree in Bud Phenomenon/ N. Ravikumar, A. Rafalowski, P. Gurung, Springfield, MA, p.A1478 P478 Ruxolitinib Discontinuation Syndrome in a Patient with Myelofibrosis to Acute Myeloid Leukemia Transformation/ A. Shakir, S. Nusrat, A. Keruakous, Oklahoma City, OK, p.A1479 P479 It’s in Her Story a Case of Cocaine Vasculitis/ J.M. Habibullah, B. Lou, A. Tsegaye, Manhasset, NY, p.A1480 P480 Unexplained Diffuse Alveolar Hemorrhage Associated with Recent Gingko Use/ W.T. Smith, J.M. Galvis, K. El-Kersh, Louisville, KY, p.A1481 Facilitator : J.M. Sill, MD, Norfolk, VA P481 Long Term Consequences of a Rare Entity: Severe Contrast Aspiration/ A. Shokunbi, K. Calero, Tampa, FL, p.A1482 P482 Isotretinoin Induced Small Vessel Vasculitis: A Life Threatening Complication/ S. Annangi, K. Donaldson, S. Pasha, Lexington, KY, p.A1483 P483 Paclitaxel-Induced Acute Bilateral Pneumonitis/ K.M. Siraj, S. Hallmeyer, Park Ridge, IL, p.A1484 P484 Complete Reversion of Ipilimumab Pneumonia by Corticosteroid and Drug Withdraw/ E.P. Oliveira, R.F. Palazzo, C.S.V. Barbas, Sao Paulo, Brazil, p.A1485 P485 Severe Complication Related to Statin-Induced Rhabdomyolysis and Myopathy/ M. Ueoka, J.D. Miles, G. Devendra, Honolulu, HI, p.A1486 P486 An Unusual Cause of Diffuse Pulmonary Hemorrhage/ A. Jain, A. Aggarwal, S. Kumar, Detroit, MI, p.A1487 P487 Onset of ILD and Exacerbation of Long Standing Myositis by Statin in Patient with Anti-HMGCR Antibody/ N.Y. Madisi, M.L. Padilla, New York, NY, p.A1488 P488 Nivolumab and Amiodorane-Induced Interstitial Lung Disease (ILD) in a Patient with Metastatic Melanoma/ J. Burgei, R. Dasgupta, I. Kim, H. Makkar, Akron, OH, p.A1489 P489 A Case of a Chylous Complication Related to Dasatinib Use/ S. O’Brien, E.D. Moloney, H. Enright, A. Dudina, M. Tolan, Dublin, Ireland, p.A1490 ATS 2019 • Dallas, TX 54 SUNDAY • MAY 19